A small percentage (about 3%) of patients with ulcerative colitis who are treated with mesalamine (5-ASA, 5-aminosalicylic acid) develop the acute intolerance syndrome with exacerbation of colitis symptoms.
To read more or access our algorithms and calculators, please log in or register.
